EcoDrugPlus

Estrogen Receptor 2

Ensembl ID : ENSLOCG00000010280
Gene Symbol: ESR2
3 Cross references
275 Possible Orthologues:

Estrogen Related Receptor Gamma

Ensembl ID : ENSLOCG00000016054
Gene Symbol: ESRRG
3 Cross references
277 Possible Orthologues:

Exportin 1

Ensembl ID : ENSLOCG00000016095
Gene Symbol: XPO1
3 Cross references
308 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSLOCG00000000791
Gene Symbol: FDFT1
3 Cross references
220 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSLOCG00000012159
Gene Symbol: FNTA
3 Cross references
221 Possible Orthologues:

Fibroblast Growth Factor Receptor 1b

Ensembl ID : ENSLOCG00000014985
Gene Symbol: FGFR1B
1 Cross references
226 Possible Orthologues:

Fibroblast Growth Factor Receptor 2

Ensembl ID : ENSLOCG00000008752
Gene Symbol: FGFR2
3 Cross references
219 Possible Orthologues:

Fibroblast Growth Factor Receptor 3

Ensembl ID : ENSLOCG00000007042
Gene Symbol: FGFR3
3 Cross references
193 Possible Orthologues:

Fms Related Receptor Tyrosine Kinase 3

Ensembl ID : ENSLOCG00000004310
Gene Symbol: FLT3
4 Cross references
133 Possible Orthologues:

Fms Related Tyrosine Kinase 1

Ensembl ID : ENSLOCG00000004379
Gene Symbol: FLT1
3 Cross references
198 Possible Orthologues:

Fms Related Tyrosine Kinase 4

Ensembl ID : ENSLOCG00000012009
Gene Symbol: FLT4
3 Cross references
193 Possible Orthologues:

Folate Hydrolase 1b

Ensembl ID : ENSLOCG00000007231
Gene Symbol: FOLH1B
3 Cross references
329 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).